News Center
Most patients walk out of a US fertility clinic believing they personally chose between a fresh and a frozen embryo transfer. In a large share of American IVF cycles, that decision was effectively made before the consultation ended, shaped by the clinic's standard protocol, the structure of its treatment packages, and the way options were framed in the exam room. Knowing how those hidden defaults work is what turns a pre-set pathway into a real choice.
The obvious answer is "my reproductive endocrinologist." The practical answer is more layered. By the time a patient sits in an exam room weighing fresh versus frozen, at least four separate decisions have already been made by other people, at other times, for other reasons.
The first decision happens at the baseline visit, when the physician selects a stimulation protocol. A protocol built around a freeze-all approach and later transfer commits the cycle to frozen before a single egg is retrieved. The second decision is administrative: the clinic's scheduling system, laboratory staffing, and batching habits determine which transfer windows even exist for a given patient. The third decision is commercial, embedded in whatever package or fee structure the patient signed. The fourth is conversational, and it is the one patients experience most directly: how the physician or nurse coordinator frames the options, what gets presented as standard, and what gets mentioned only if the patient asks.
None of this implies anyone is acting in bad faith. It does mean the "choice" is often a ratification of a pathway that was assembled without the patient in the room. The public data supports how much variation exists. The Society for Assisted Reproductive Technology publishes clinic-specific outcome reports at sart.org, and its online system breaks each clinic's cycles into fresh and frozen categories. The CDC's Assisted Reproductive Technology surveillance reports, available through cdc.gov/art, describe the same landscape at the national level. Clinics in the same city, treating similar populations, report materially different fresh-versus-frozen distributions. If the medical evidence pointed to one universally correct approach, that variation would not survive. The variation survives because a meaningful part of the difference reflects clinic habit, laboratory workflow, and business structure rather than patient characteristics alone.
Every clinic runs on a default pathway, and the defaults differ for reasons that predate any individual patient.
Historical training matters. Physicians who completed fellowship before vitrification became widespread trained in an era when fresh transfer was the norm, because older slow-freezing methods produced weaker outcomes and freezing embryos carried a real cost. Vitrification changed the calculus: survival rates after thawing became high enough that frozen transfer stopped being a compromise. Clinics whose leadership embraced that shift early moved heavily toward freeze-all workflows. Clinics with physicians trained in the older paradigm, or with laboratories less confident in their thaw outcomes, retained fresh transfer as a routine option for good-prognosis patients.
Laboratory capacity shapes defaults too. A freeze-all approach concentrates work: the embryology team can batch retrievals, schedule embryo assessments during staffed weekday hours, and avoid weekend thaw-and-transfer logistics. A high fresh-transfer rate demands more flexible laboratory coverage, because a fresh transfer must happen on a specific day dictated by the patient's cycle, whether or not that day is convenient. A clinic that has invested in weekend laboratory staffing can offer fresh transfer broadly. A clinic that runs a leaner lab schedule will find freeze-all both medically defensible and operationally comfortable. The medical rationale and the operational preference point in the same direction, which is precisely why patients rarely hear the operational half of the reasoning.
Physician-level variation within a single clinic is the detail patients overlook most often. Two reproductive endocrinologists sharing an office, an embryology lab, and a nursing team can still run noticeably different fresh-versus-frozen patterns for comparable patients, because protocol selection is an individual clinical judgment. The clinic's published aggregate ratio may describe neither of them accurately. This is one reason the questions later in this article specify "my cycle" rather than "your clinic."
None of these defaults is inherently wrong. A clinic that freezes everything for everyone is not automatically over-treating, and a clinic with a high fresh rate is not automatically outdated. The problem is informational: when the default is invisible, the patient cannot evaluate whether it fits her specific situation, and consent to a pathway she cannot see is consent in name only.
Treatment packages are marketed as financial products, and they function that way. They also function as clinical decision filters, and this second function almost never appears in the sales conversation.
Consider how multi-cycle and refund-style programs are typically structured across the American market. These programs generally bundle multiple retrievals, embryo freezing, genetic testing of embryos, and a defined number of frozen transfers into one agreement. A patient enrolled in such a program has, structurally, no fresh-transfer pathway at all. The program's architecture assumes banking frozen embryos across cycles and then transferring from that bank. Nobody tells the patient "you are excluded from fresh transfer." She simply never encounters the option, because the package she purchased does not contain it. The financial commitment quietly became a clinical commitment.
Storage arrangements create a second, gentler steering force. Frozen embryos accrue annual storage fees after an initial included period, and some programs tie discounts or guarantees to completing transfers within a defined window. A patient facing ongoing storage costs and a program deadline has a financial nudge toward transferring sooner, and possibly toward additional retrievals to build a larger bank before transferring, depending on how the agreement is worded. The nudge may align with good medicine in her case. It may not. Either way, it is a factor she was not told about when the package was described as "covering everything."
The general principle is worth naming: whatever a package bundles determines what gets discussed. A package built around frozen embryo banking makes frozen transfer the path of least resistance in every subsequent conversation. A pay-per-cycle arrangement keeps both options live but may leave the patient exposed to unbundled costs, and the clinic's default then operates through protocol selection rather than package terms. Fee structures vary widely across US clinics, and patients should verify current terms against each clinic's published fee schedule rather than relying on general descriptions, including the ones in this article.
One practical implication follows from all of this. If you have not yet signed anything, the moment to ask how the package shapes transfer strategy is before signing, while the clinic still has an incentive to explain its logic. After the agreement is signed, the package terms become the answer to most of your questions, whether or not they were designed with your physiology in mind.
Information asymmetry in medicine is not solved by reading more articles. It is solved by asking questions the other side has not prepared a script for. The three questions below are designed to expose the decision structure of a specific clinic for a specific patient. Ask them in order, and pay attention to how they are answered as much as to what is said.
This question has two parts, and the second part does the real work. Many clinics can produce their fresh-versus-frozen split from their own records; the SART reporting system requires cycle-type data, so the number exists somewhere in their files. A clinic that cannot or will not state its own ratio is telling you something about how internally visible its own practice patterns are.
The reasoning part matters more. If the answer is "we freeze everything because frozen outcomes are better," ask what that means for your specific prognosis. For a patient at elevated risk of ovarian hyperstimulation syndrome, a freeze-all approach has a well-documented safety rationale, and the American Society for Reproductive Medicine's patient materials on OHSS describe this directly. For a patient with a low-response pattern and a single embryo, the calculus is different, and a blanket freeze-all policy may reflect workflow preference as much as individualized judgment. A clinic that can articulate why its default fits your category is practicing medicine. A clinic that repeats the same sentence regardless of your profile is running a protocol.
Cycles change. Monitoring bloodwork comes back outside expected ranges, follicles develop unevenly, the uterine lining behaves unexpectedly. The relevant question is organizational: when that happens on a Saturday, does the change require the physician who designed your protocol, or can the on-call physician or senior nurse coordinator act? Is there a written escalation process, or does everything queue until Monday?
Clinics answer this question in revealing ways. Some describe a clear chain: named physician oversight, defined triggers for protocol changes, and coordinator-level authority for time-sensitive adjustments under standing orders. Others describe a vaguer arrangement in which "the team reviews everything," which often translates to decisions clustering around the primary physician's availability. Neither model guarantees a good outcome, but the first model tells you that mid-cycle flexibility was designed into the practice, while the second tells you it will be improvised around your specific crisis. Since the fresh-versus-frozen switch is one of the most common mid-cycle changes, the answer to this question directly measures how real your transfer options are.
This is the sharpest question of the three, because it forces the clinic to state its decision triggers in advance. A clinic with genuine individualized decision-making can list concrete criteria: a progesterone level on the day of trigger above a defined threshold, an endometrial pattern or fluid finding on monitoring ultrasound, an estradiol and follicle-count combination suggesting hyperstimulation risk, an unexpected fever or illness, or a fertilization result that changes the number of embryos available. The precise thresholds vary by physician and are beyond the scope of this article, and you should not treat any threshold you read online as a standard. What you are testing is whether specific triggers exist in this clinic's practice at all.
A vague answer, such as "we decide based on how everything looks," indicates that the switch is made case by case at the physician's discretion without pre-committed criteria. That approach can still produce good care in experienced hands. It also means the patient has no way to anticipate the decision, no basis for a second opinion, and no written record of why a pathway changed. Clinics confident in their logic are generally comfortable naming their triggers; discomfort with the question is itself diagnostic.
Across consultations, the answers to those three questions tend to sort clinics into three recognizable patterns.
The first pattern is protocol-driven. Every patient with a given diagnosis receives essentially the same pathway, the fresh-frozen ratio is stable and extreme in one direction, and the justifications are delivered as general statements rather than patient-specific reasoning. This model produces consistency and operational efficiency. Its weakness is that the patient's individual physiology enters the decision mainly as an exception to be managed, rather than as the starting point.
The second pattern is physician-driven. The clinic's aggregate numbers look moderate, but the actual decision varies by which physician a patient sees, and the office itself may not track that variation. Patients who want to understand their own likely pathway need to ask about their specific doctor's practice, not the clinic's brochure. This pattern is common in larger multi-physician practices and is not a flaw in itself, but it makes the clinic-level statistics less useful for personal planning than patients assume.
The third pattern is evidence-driven at the individual level. The clinic knows its numbers, states its triggers, and can explain why a given patient is being routed toward fresh or frozen using findings from her own monitoring. This is the pattern the three questions are designed to identify, and it exists in practices of every size.
There is also a quieter alignment worth understanding honestly. Freeze-all workflows simplify scheduling, reduce weekend laboratory demands, and smooth embryology staffing across the week. A default that serves the clinic operationally can simultaneously serve high-risk patients medically, and both things are true at once. The goal of asking these questions is not to catch the clinic in a contradiction. The goal is to know which force is operating in your cycle, so that when the plan is presented as being "for your benefit," you can judge that claim on its merits.
The following scenario is a composite constructed for illustration, not a record of any real patient, and it shows how identical medical facts can travel down different pathways depending on the clinic's defaults.
Take a hypothetical 32-year-old with regular cycles, good ovarian reserve, and a first IVF cycle ahead of her. At Clinic A, the baseline consultation includes a stimulation protocol that ends in a freeze-all, with transfer scheduled in a subsequent cycle after genetic testing. The nurse coordinator explains this as "our standard approach, it gives the best outcomes." The patient signs, and the pathway is set. At Clinic B, the same baseline visit produces a plan for fresh transfer of a single embryo if monitoring stays within range, with freezing held as the contingency if her progesterone rises or her response looks excessive. Same diagnosis, same age, same first cycle. The difference is that Clinic A's default was applied before her individual monitoring existed, while Clinic B's plan keeps the decision open until her own data is in.
Now insert the three questions. At Clinic A, the patient asks what percentage of cycles are fresh. The answer is a small fraction, and the reasoning offered is uniform across patient types. She asks what findings would trigger a mid-cycle switch, and the answer is general. She now knows her pathway was set administratively, and she can either accept that with open eyes, request an individualized rationale, or consult elsewhere. At Clinic B, the physician names specific monitoring thresholds and explains who acts on them over a weekend. The patient still cannot control the outcome, but she can see the machinery, and she can hold the clinic to the criteria it stated.
The scenario's lesson is uncomfortable but useful. The patient at Clinic A was never lied to, and her care may proceed without complications. What she lost was the opportunity to evaluate the decision, because the decision was never presented as a decision. Patients who ask the three questions convert that hidden pathway into an explicit one, and explicit pathways can be examined, negotiated, or declined.
Several widespread beliefs hand the decision back to the clinic by making the patient stop asking. Each is worth correcting.
A brief orientation to the common triggers helps patients recognize when a proposed switch is standard practice rather than an arbitrary change. The list below is general education, and the thresholds themselves are set by each physician.
Patients should also know the switch runs in both directions. A planned freeze-all cycle occasionally converts to fresh discussion when monitoring is textbook and the patient's circumstances favor it, though this is less common. The direction of the switch matters less than whether the clinic can point to a specific finding that caused it. A switch explained by data is medicine. A switch explained by scheduling deserves a follow-up question.
Transparency about decision-making is a trait of individual practices rather than of any single market, and patients comparing options can evaluate it directly using the questions in this article. A few examples illustrate the range of organizational models a patient might encounter, and how each model affects the fresh-versus-frozen conversation.
HRC Fertility operates multiple locations across California within a large group practice structure. In a multi-site, multi-physician organization of this kind, protocol patterns can differ between locations and between physicians, which makes the physician-specific question especially relevant: patients should ask about their own doctor's fresh-versus-frozen approach rather than relying on group-level descriptions.
CNY Fertility in New York State runs a high-volume, lower-cost model. High patient volume tends to standardize workflows, since standardization is how large volumes are managed safely, so patients there should expect a defined default pathway and should ask specifically what findings allow deviation from it. The volume model can work well for patients whose profile fits the standard pathway, and the three questions will reveal quickly whether it does.
New Hope Fertility Center in Manhattan serves a substantial international patient population, which introduces a further layer: patients traveling from abroad often have compressed schedules, and compressed schedules interact directly with fresh-versus-frozen logistics, since a frozen transfer requires either a second trip or coordination with a monitoring provider near the patient's home. International patients should ask how the clinic sequences monitoring, retrieval, and transfer across borders before committing to a pathway.
Whatever the practice, patients can and should verify clinic-level cycle data independently through the SART clinic reports at sart.org and the CDC's ART reporting at cdc.gov/art, both of which break out fresh and frozen cycles. Published outcome data describe populations; the three questions in this article describe your cycle. Use both.
Verbal answers fade. A short written checklist keeps the conversation anchored and creates a record you can compare across clinics.
Two of these items, the package terms and the storage terms, exist in the consent and agreement documents regardless of what is said aloud. Asking for the relevant pages and reading them before signing costs nothing and resolves most of the quiet steering described earlier in this article.
The fresh-versus-frozen question is usually presented as a medical question, and it is partly one. It is also an organizational question and a contractual one, and those dimensions determine the medical question's range of possible answers before you ever weigh in. Clinics with freeze-all defaults, clinics with high fresh rates, and clinics that individualize heavily can all deliver excellent care to the right patients. The difference is that only the last group can tell you, specifically, why their pathway fits yours.
Your leverage comes from asking about the machinery before you are inside it. Ask for the clinic's ratio, then for your physician's pattern. Ask who can change your plan on a Sunday and on what evidence. Ask what findings would flip the transfer type, and listen for whether the answer contains numbers and findings or only reassurance. The answers will not tell you which procedure is best. They will tell you whether the decision you are about to make was ever actually yours to make, and that knowledge is worth more than any single cycle's outcome data.
